The device focuses on examining sonoporation-based drug delivery that involves ultrasound-based treatment with microbubbles.

The upcoming report from Abbott (ABT) is expected to reveal quarterly earnings of $1.25 per share, indicating an increase of 9.7% compared to the year-ago period. Analysts forecast revenues of $11.07 ...

The global Brain Pacemaker Market represents a rapidly expanding segment of the medical device industry, valued at USD 3.66 ...

Detailed price information for Abbott Laboratories (ABT-N) from The Globe and Mail including charting and trades.

This work presents a modular, light-weight head-borne neuromodulation platform that achieves low-power wireless neuromodulation and allows real-time programmability of the stimulation parameters such ...

Benzinga tracks 150 analyst firms and reports on their stock expectations. Analysts typically arrive at their conclusions by predicting how much money a company will make in the future, usually the ...

This editorial attempts to summarize the contributions of the articles published under the Research Topic neuromodulation, which is a part of a series that showcases some of the most notable advances ...

For exclusive news and updates, subscribe to our Abbott Elementary Newsletter: As Abbott Elementary returns for Season 5 this fall, series creator and star Quinta Brunson is questioning when the ...

Texas renews Healthy Texas Women Medicaid waiver until 2030, securing services like cancer screenings and contraception for low-income women.